Bookmark

Add to MyYahoo RSS

Salix Pharmaceuticals News

News on Salix Pharmaceuticals (Ticker: SLXP) continually updated from thousands of sources around the net.

19 hrs ago | Investor's Business Daily

Salix Pharmaceuticals Forms Secondary Entry

Medical-sector leader Salix Pharmaceuticals has been trading tightly for a few weeks and has created a follow-on pattern.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Jul 24, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Research and Markets: Global Construction Industry 2014-2019: Market is Expected to Reach an Estimated Value of $10,388.6 Billion by 2019 )--Research and Markets has announced the addition of the "Global Construction Industry 2014-2019: Trends, Profits a... )--Oxea introduces stabilized TOTM under the brand name Oxsoft TOTM ST into its ... (more)

Comment?

Related Topix: Banking, Financial Services, Macquarie Bank, Biotech, Medicine, Healthcare Industry, Westminster, CA, San Diego, CA

Seeking Alpha

Redhill Biopharma's (RDHL) CEO Dror Ben Asher on Q2 2014 Results - Earnings Call Transcript

Good day and welcome to the Redhill Biopharma Q2 2014 Financial Results and Business Highlights Conference Call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Investor's Business Daily

Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference...

Salix Pharmaceuticals, Ltd. today announced that the Company will report second quarter 2014 financial results following the close of the U.S. financial markets on Thursday, August 7, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Raleigh, NC

Wed Jul 23, 2014

Customer Interaction Solutions

RedHill Biopharma Reports Results for the Second Quarter of 2014

RedHill Biopharma Ltd. , an Israeli biopharmaceutical company focused on late clinical-stage drugs for inflammatory and gastrointestinal diseases, including cancer, today reported financial results for the quarter ended June 30, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jul 21, 2014

Seeking Alpha

An Inefficient Stock Market Will Catch Up To Progenics

The FDA recently informed Progenics and partner Salix that the opioid induced constipation drug, Relistor, can be approved for an expanded indication.

Comment?

Related Topix: Biotech, Medicine, Progenics Pharmaceuticals, Healthcare Industry, Healthcare Law, Law, Constipation, Health, Marketing, Palliative Care

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

In addit... )--CASH AMERICA INTERNATIONAL, INC. , a leading provider of specialty financial services to individuals, will hold its quarterly conference call to discu... )--Gen Re announced a number of senior appointments in the Asia Pacific region.

Comment?

Related Topix: Cash America International, Financial Services, Biotech, Medicine, Healthcare Industry, Round Rock, TX

Sun Jul 20, 2014

Bloomberg

Merger Rush for Offshore Tax Break Bets on U.S. Stalemate

U.S. companies are racing to complete tax-reducing offshore mergers before a credible threat to stop them emerges from Congress.

Comment?

Related Topix: US News, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech, Shire plc, US Politics, US Senate, Ron Wyden, Democrat, Orrin Hatch, Republican

Fri Jul 18, 2014

Medical News Today

FDA approval announced of Ruconest for the treatment of acute...

Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Genetics, Health

Thu Jul 17, 2014

Business Journal

Treasury secretary seeks to prevent foreign deals like Salix merger

The Obama administration came out in sharp opposition to the kind of business merger that Raleigh's Salix Pharmaceuticals announced on July 8 and Treasury Secretary Jacob Lew urged Congress to pass retroactive legislation that could put the deal in jeopardy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, US News

The Salinas Californian

Companies take US benefits, but flee US taxesCompanies take US...

Companies take US benefits, but flee US taxes Merging and reincorporating abroad to avoid taxes is called an inversion.

Comment?

Related Topix: US News, US Supreme Court, Biotech, Medicine, Healthcare Industry, Opinion

Investor's Business Daily

Salix and Pharming Announce FDA Approval of RUCONEST for the...

RUCONEST A 50 IU/kg IS The First and Only Recombinant Treatment Option for Adult and Adolescent Patients Suffering from Hereditary Angioedema RALEIGH, N.C. & LEIDEN, The Netherlands-- -- Salix Pharmaceuticals, Ltd. and Pharming Group NV today announced that the Food and Drug Administration has approved RUCONESTA 50 IU/kg for the treatment of acute ... (more)

Comment?

Related Topix: Biotech, Food and Drug Administration, Medicine, Healthcare Industry, Genetics

Customer Interaction Solutions

Salix and Pharming Announce FDA Approval of RUCONEST for the...

Salix and Pharming Announce FDA Approval of RUCONEST for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema Salix Pharmaceuticals, Ltd. and Pharming Group NV today announced that the Food and Drug Administration has approved RUCONEST 50 IU/kg for the treatment of acute angioedema attacks in adult and adolescent ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Genetics

Wed Jul 16, 2014

SBWire

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) Investor Alert:...

An investigation on behalf of investors, who currently hold shares of Salix Pharmaceuticals, Ltd. shares, was announced concerning whether the takeover of Salix Pharmaceuticals, Ltd. by Cosmo Pharmaceuticals S.p.A is unfair to NASDAQ:SLXP stockholders.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 15, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Salix Pharmaceuticals, Ltd. and Its Board of Directors In Connection With the Sale of the Company to Cosmo Technologies Limited )--Levi & Korsinsky is investigating the Board of Directors of Salix Pharmaceuticals, Ltd. for possible breaches of fiduciary duty and other violations of ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Banking, Financial Services, Franklin Financial

Bloomberg

Italian Ajani Emerges as Drug Billionaire in Switzerland

Mauro Ajani loves his native Italy . That's why in 2006 he tried to list Cosmo Pharmaceuticals SpA , the drugmaker he founded a decade earlier, in his hometown of Milan.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Raleigh, NC

Mon Jul 14, 2014

Myrtle Beach Online

Companies take US benefits, but flee US taxes

The U.S. Supreme Court keeps telling us that corporations are people, but some of these "people" have a curious sense of patriotism.

Comment?

Related Topix: US News, US Supreme Court, Biotech, Medicine, Healthcare Industry, Education

Investor's Business Daily

FDA Office of Drug Evaluation III Approves Salix's Request that the...

Post-marketing Observations Cohort Study Required to Assess Relative Incidence of MACE in Patients using RELISTOR Subcutaneous Injection Compared to Patients Using Other Comparator Treatments for Opioid-induced Constipation RALEIGH, N.C. & TARRYTOWN, N.Y.-- -- Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals today announced that the Food ... (more)

Comment?

Related Topix: Biotech, Healthcare Industry, Food and Drug Administration, Marketing, Progenics Pharmaceuticals

GlobeNewswire

Progenics Holds Conference Call This Morning on FDA Appeal Response...

Progenics Pharmaceuticals, Inc. chief executive officer Mark Baker will comment on the FDA's Relistor Appeal Response in a conference call this morning, Monday, July 14, at 8:30 a.m. Eastern Time .

Comment?

Related Topix: Biotech, Progenics Pharmaceuticals, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Oncology

Thu Jul 10, 2014

Investor's Business Daily

Salix Shareholder Alert: Former Sec Attorney Willie Briscoe and...

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Salix Pharmaceuticals, Ltd. concerning the merger with Cosmo Tech, a subsidiary of Cosmo Pharmaceuticals.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••